Literature DB >> 15619112

The use of sudden darkness in mice: a behavioural and pharmacological approach.

Bettina Bert1, Luciano F Felicio, Heidrun Fink, Antonia G Nasello.   

Abstract

Sudden darkness is a non-invasive behavioural analysis tool which increases motor activity and decreases anxiety in rats. It has been shown in previous studies that in rats, dark test conditions can also modify behavioural responses to drugs acting on the dopaminergic system. The increasing use of transgenic mice in behavioural research has raised interest in developing new tests for phenotyping mice. Hence, the aim of the present study was to adapt the sudden darkness paradigm for mice. In the first part of this study, effects of sudden darkness on the performance of mice in the elevated plus maze test were evaluated. Both genders of two mouse strains (Swiss and Balb/c) were tested either in high light intensity conditions or were exposed to sudden darkness. In the second part, responses to the 5-HT(1A) receptor agonist 8-OH-DPAT (0.5 and 1.0 mg/kg) and 5-HT(2C) receptor agonist mCPP (1.0 and 2.0 mg/kg) were investigated in male Swiss mice. Sudden darkness induced a clear anxiolytic effect in male and female Swiss mice. In Balb/c mice, anxiety-related behaviour was only decreased in females, whereas in males the anxiety state remained unchanged. An increase in motor activity was only observed in male Swiss mice; in the other groups, sudden darkness did not affect locomotion. Depending on the light conditions used, the behavioural response to receptor agonists was more evident: 8-OH-DPAT (1.0 mg/kg) only significantly decreased the anxiety state when mice were tested under high levels of illumination, whereas the anxiogenic effect of mCPP (1.0 and 2.0 mg/kg) was only evident in the dark. This study suggests that the sudden darkness paradigm is also a useful tool for the analysis of mice and can be used to modulate the anxiety level without administering drugs. Depending on the mouse strain tested, the same effects on anxiety and motor activity were observed as have been shown for rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15619112     DOI: 10.1007/s00213-004-2107-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Influence of circadian phase and test illumination on pre-clinical models of anxiety.

Authors:  N Jones; S M King
Journal:  Physiol Behav       Date:  2001-01

2.  Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT.

Authors:  S M Remy; R Schreiber; M Dalmus; J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 3.  Animal models of anxiety and depression: how are females different?

Authors:  P Palanza
Journal:  Neurosci Biobehav Rev       Date:  2001-05       Impact factor: 8.989

4.  Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.

Authors:  T Berger; B Lemmer
Journal:  Pol J Pharmacol Pharm       Date:  1976 Nov-Dec

5.  Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.

Authors:  G Griebel; C Belzung; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  2000-02       Impact factor: 4.530

6.  Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: effects of novelty and handling and comparison to the nucleus accumbens.

Authors:  M G Feenstra; M H Botterblom; S Mastenbroek
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

7.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

Review 8.  Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety.

Authors:  Michael B Gatch
Journal:  Life Sci       Date:  2003-08-01       Impact factor: 5.037

9.  Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

Authors:  G Griebel; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1998-07       Impact factor: 4.530

10.  The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze.

Authors:  D Benjamin; H Lal; L R Meyerson
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

View more
  3 in total

1.  Conversion of short-term to long-term memory in the novel object recognition paradigm.

Authors:  Shannon J Moore; Kaivalya Deshpande; Gwen S Stinnett; Audrey F Seasholtz; Geoffrey G Murphy
Journal:  Neurobiol Learn Mem       Date:  2013-07-05       Impact factor: 2.877

2.  New evidence of ethanol's anxiolytic properties in the infant rat.

Authors:  Roberto Sebastián Miranda-Morales; Michael E Nizhnikov; Dustin H Waters; Norman E Spear
Journal:  Alcohol       Date:  2014-04-08       Impact factor: 2.405

3.  The clinical implications of mouse models of enhanced anxiety.

Authors:  Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Future Neurol       Date:  2011-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.